Treatment used in poor countries to prevent HIV passing from mothers to babies may have a serious drawback. Research suggests it may reduce the drug’s effectiveness when it is needed later by the women themselves.
Treatment used in poor countries to prevent HIV passing from mothers to babies may have a serious drawback. Research suggests it may reduce the drug’s effectiveness when it is needed later by the women themselves.